Abstract
A variety of local hemostats including absorbable gelatin sponge, collagen hemostat, and oxidized cellulose are commercially available. Local hemostats are applied when cautery, ligature, or other conventional hemostatic method is impractical. Proper handling is essential to control bleeding and only the required amount should be used, even though the hemostat is expected to dissolve promptly. A dry local hemostat absorbs body fluid of several times its own weight and expands postoperatively. Therefore, when an absorbable hemostatic agent is retained on or near bony or neural spaces, the minimum amount should be left after hemostasis is achieved. Documentation is important with regard to the hemostat used, including the name of the agent, site, and amount. This information is used as a reference in the interpretation of postoperative diagnostic images, since retained hemostat may sometimes mimic an abscess or recurrent tumor. The antigenicity of collagen is known to be low because of homology. When the safety of collagen was evaluated, the incidence of positive reactions was reported as 3.0%, and collagen may cause allergic reactions. Minimum inflammation without strong foreign body reactions or blockade of healing is desirable after the use of local hemostats. Strong foreign body reactions, chronic inflammation, and infections can cause granuloma formation after local hemostat use. By using local hemostats, it is possible to improve the condition of the patient, reduce complications, and lower direct and indirect costs.
Similar content being viewed by others
References
E Gray (1915) ArticleTitleFibrin as a hemostatic in cerebral surgery Surg Gynecol Obstet 21 452–454
S Harvey (1916) ArticleTitleThe use of fibrin paper and foams in surgery Boston Med Surg 174 658–659
V Frantz (1943) ArticleTitleAbsorbable cotton, paper and gauze (oxidized cellulose) Ann Surg 118 116–126
J Correll E Wise (1945) ArticleTitleCertain properties of a new physiologically absorbable sponge Proc Soc Exp Bio Med 58 233–235
T Natsume N Okumura Y Shimizu (1993) ArticleTitleA cotton-like fibrous collagen hemostatic agent Jpn J Artif Organs 22 348–352
T Miyata T Taira Y Noishiki (1992) ArticleTitleCollagen engineering for biomaterial use Clin Mater 9 139–148
Y Tomizawa M Komori K Takada H Nishida M Endo H Kurosawa (2002) ArticleTitleConditions to accelerate vessel formation in wound healing J Jpn Coron Assoc 8 38–40
Y Tomizawa M Komori K Takada H Nishida M Endo H Kurosawa (2003) ArticleTitleIn vivo evaluation of collagen hemostats: biocompatibility and resorption Jpn J Cardiovasc Surg 32 17–22
R Timpl (1984) Immunology of the collagens K Piez A Reddi (Eds) Extracellular matrix biochemistry Elsevier New York 159–190
K Stenzel T Miyata A Rubin (1974) ArticleTitleCollagen as a biomaterial Annu Rev Biophys Bioeng 3 231–253
F DeLustro RA Condell MA Nguyen JM McPherson (1986) ArticleTitleA comparative study of the biologic and immunologic response to medical devices derived from dermal collagen J Biomed Mater Res 20 109–120
LS Cooperman V Mackinnon G Bechler BB Pharriss (1985) ArticleTitleInjectable collagen: a six-year clinical investigation Aesthetic Plast Surg 9 145–151
InstitutionalAuthorNameThe Canadian Multicenter Hemashield Study Group (1990) ArticleTitleImmunologic response to collagen-impregnated vascular grafts: a randomized prospective study J Vasc Surg 12 741–746
K Kitamura R Yasuoka M Ohara M Shimotsuma A Hagiwara T Yamane T Yamaguchi T Takahashi (1995) ArticleTitleHow safe are the xenogeneic hemostats? Report of a case of severe systemic allergic reaction Surg Today 25 433–435
M Chvapil JA Owen DW DeYoung (1983) ArticleTitleA standardized animal model for evaluation of hemostatic effectiveness of various materials J Trauma 23 1042–1047
ME Silverstein K Keown JA Owen M Chvapil (1980) ArticleTitleCollagen fibers as a fleece hemostatic agent J Trauma 20 688–694
E Solheim OG Anfinsen H Holmsen E Sudmann (1991) ArticleTitleEffect of local hemostatics on platelet aggregation Eur Surg Res 23 45–50
WR Wagner JM Pachence J Ristich PC Johnson (1996) ArticleTitleComparative in vitro analysis of topical hemostatic agents J Surg Res 66 100–108
WC Chapman SM Wren GS Lebovic M Malawer R Sherman JE Block (2002) ArticleTitleEffective management of bleeding during tumor resection with a collagen-based hemostatic agent Am Surg 68 802–807
C Alpaslan GH Alpaslan T Oygur (1997) ArticleTitleTissue reaction to three subcutaneously implanted local hemostatic agents Br J Oral Maxillofac Surg 35 129–132
RJ Tamargo JI Epstein CS Reinhard M Chasin H Brem (1989) ArticleTitleBrain biocompatibility of a biodegradable, controlled-release polymer in rats J Biomed Mater Res 23 253–266
Y Tomizawa (2004) ArticleTitleIn vitro and in vivo evaluation of the biocompatibility and cytotoxicity of local hemostatic agents Jpn J Cardiovasc Surg 33 382–386
Y Tomizawa M Endo M Kitamura A Shiikawa Y Yagi H Koyanagi (1991) ArticleTitleCoronary artery bypass graft stenosis suspected to be due to hemostatic agents: a case report Kyobu Geka 44 764–766
T Igari F Iwaya T Abe K Hagiwara M Tanji H Satokawa M Watanabe H Midorikawa Y Sato M Kashida T Ono S Hoshino (1990) ArticleTitleA case of foreign body granuloma after aortic valve replacement Kyobu Geka 43 550–552
MF Ibrahim C Aps CP Young (2002) ArticleTitleA foreign body reaction to Surgicel mimicking an abscess following cardiac surgery Eur J Cardiothorac Surg 22 489–490
JL Ibarrola JE Bjorenson BP Austin H Gerstein (1985) ArticleTitleOsseous reactions to three hemostatic agents J Endod 11 75–83
JE Bjorenson HF Grove MG List SuffixSr GC Haasch BP Austin (1986) ArticleTitleEffects of hemostatic agents on the pH of body fluids J Endod 12 289–292
N Magro-Ernica O Magro-Filho I Rangel-Garcia (2003) ArticleTitleHistologic study of use of microfibrillar collagen hemostat in rat dental sockets Braz Dent J 14 12–15
TA Barbolt M Odin M Leger L Kangas (2001) ArticleTitlePre-clinical subdural tissue reaction and absorption study of absorbable hemostatic devices Neurol Res 23 537–542
KJ Smith HG Skelton TL Barrett M Welch J Beard (1996) ArticleTitleHistologic and immunohistochemical features in biopsy sites in which bovine collagen matrix was used for hemostasis J Am Acad Dermatol 34 434–438
JG Green TM Durham (1991) ArticleTitleApplication of INSTAT hemostat in the control of gingival hemorrhage in a patient with thrombocytopenia. A case report Oral Surg Oral Med Oral Pathol 71 27–30
OR Beirne JR Koehler (1996) ArticleTitleSurgical management of patients on warfarin sodium J Oral Maxillofac Surg 54 1115–1118
P Dineen (1976) ArticleTitleAntibacterial activity of oxidized regenerated cellulose Surg Gynecol Obstet 142 481–486
P Dineen (1977) ArticleTitleThe effect of oxidized regenerated cellulose on experimental intravascular infection Surgery 82 576–579
GB Hill (1978) ArticleTitleEnhancement of experimental anaerobic infections by blood, hemoglobin, and hemostatic agents Infect Immun 19 443–449
KS Scher JA Coil SuffixJr (1982) ArticleTitleEffects of oxidized cellulose and microfibrillar collagen on infection Surgery 91 301–304
F Robicsek GD Duncan GV Born HA Wilkinson TN Masters M McClure (1986) ArticleTitleInherent dangers of simultaneous application of microfibrillar collagen hemostat and blood-saving devices J Thorac Cardiovasc Surg 92 766–770
M McClure GD Duncan GV Born F Robicsek (1987) ArticleTitleIn vitro effect of a microfibrillar collagen hemostat on platelets Haemostasis 17 349–352
Y Tomizawa Y Noishiki M Endo A Hashimoto H Koyanagi (1996) ArticleTitleEvaluation of blood absorption, hemostatic ability and purity of a polyepoxy compound cross-linked cotton-type collagen hemostat Kyobu Geka 49 126–129
MD Orr AG Ferdman JG Maresh (1994) ArticleTitleRemoval of Avitene microfibrillar collagen hemostat by use of suitable transfusion filters Ann Thorac Surg 57 1007–1011
G Gondo T Yamashita Y Ishiwata K Hirata M Satoh (1989) ArticleTitlePeculiar computed tomographic images after intracranial use of microfibrillar collagen hemostat: report of three cases No Shinkei Geka 17 1067–1071
GS Sandhu JA Elexpuru-Camiruaga S Buckley (1996) ArticleTitleOxidized cellulose (Surgicel) granulomata mimicking tumour recurrence Br J Neurosurg 10 617–619
KF Kothbauer GI Jallo J Siffert E Jimenez JC Allen FJ Epstein (2001) ArticleTitleForeign body reaction to hemostatic materials mimicking recurrent brain tumor. Report of three cases J Neurosurg 95 503–506
T Ribalta IE McCutcheon AG Neto D Gupta AJ Kumar DA Biddle LA Langford JM Bruner NE Leeds GN Fuller (2004) ArticleTitleTextiloma (gossypiboma) mimicking recurrent intracranial tumor Arch Pathol Lab Med 128 749–758
A Oto EM Remer CM O'Malley JA Tkach IS Gill (1999) ArticleTitleMR characteristics of oxidized cellulose (Surgicel) AJR Am J Roentgenol 172 1481–1484
M Spiller MS Tenner WT Couldwell (2001) ArticleTitleEffect of absorbable topical hemostatic agents on the relaxation time of blood: an in vitro study with implications for postoperative magnetic resonance imaging J Neurosurg 95 687–693
F Patane E Zingarelli A Verzini M di Summa (2001) ArticleTitleComplication due to excessive use of Surgicel Eur J Cardiothorac Surg 20 1034
F van Gelderen J Swinnen (1996) ArticleTitleAppearance of oxidized cellulose (Surgicel) on abdominal radiographs AJR Am J Roentgenol 167 1593
JW Melamed EK Paulson MA Kliewer (1995) ArticleTitleSonographic appearance of oxidized cellulose (Surgicel): pitfall in the diagnosis of postoperative abscess J Ultrasound Med 14 27–30
ST Young EK Paulson RL McCann ME Baker (1993) ArticleTitleAppearance of oxidized cellulose (Surgicel) on postoperative CT scans: similarity to postoperative abscess Am J Roentgenol 160 275–277
BR Turley RE Taupmann PL Johnson (1994) ArticleTitlePostoperative abscess mimicked by Surgicel Abdom Imaging 19 345–346
AR O'Connor FV Coakley MV Meng S Eberhardt (2003) ArticleTitleImaging of retained surgical sponges in the abdomen and pelvis Am J Roentgenol 180 481–489
VL Schiller P Joyce D Sarti (1994) ArticleTitleHemostatic agent and concomitant abdominal abscess Am J Roentgenol 162 236
S Iwabuchi K Koike T Okabe S Tago T Murakami (1997) ArticleTitleIatrogenic paraplegia caused by Surgicel used for hemostasis during a thoracotomy: report of a case Surg Today 27 969–970
AR Brodbelt JB Miles PM Foy JC Broome (2002) ArticleTitleIntraspinal oxidized cellulose (Surgicel) causing delayed paraplegia after thoracotomy – a report of three cases Ann R Coll Surg Engl 84 97–99
RZ Lovstad PA Steen M Forsman (1999) ArticleTitleParaplegia after thoracotomy – not caused by the epidural catheter Acta Anaesthesiol Scand 43 230–232
EE Awwad KR Smith SuffixJr (1999) ArticleTitleMRI of marked dural sac compression by Surgicel in the immediately postoperative period after uncomplicated lumbar laminectomy J Comput Assist Tomogr 23 969–975
DH Alander ES Stauffer (1995) ArticleTitleGelfoam-induced acute quadriparesis after cervical decompression and fusion Spine 20 970–971
J Friedman TS Whitecloud SuffixIII (2001) ArticleTitleLumbar cauda equina syndrome associated with the use of Gelfoam: case report Spine 26 E485–E487
FDA Public Health Notification: Paralysis from absorbable hemostatic agent. Feb 4, 2004. http://www.fda.gov/cdrh/safety/040204-hemostatics.html
JJ Dutton DT Tse RL Anderson (1983) ArticleTitleCompressive optic neuropathy following use of intracranial oxidized cellulose hemostat Ophthalmic Surg 14 487–490
T Nakayama K Shimazaki J Ono K Ohsato A Yamaura (1994) ArticleTitleIntracranial foreign body granuloma caused by fine cotton fibers: a case report No Shinkei Geka 22 1081–1084
H Ito H Onishi K Shoin H Nagatani (1989) ArticleTitleGranuloma caused by oxidized cellulose following craniotomy Acta Neurochir (Wien) 100 70–73
M Nakajima T Kamei K Tomimatu T Manabe (1995) ArticleTitleAn intraperitoneal tumorous mass caused by granulomas of microfibrillar collagen hemostat (Avitene) Arch Pathol Lab Med 119 1161–1163
DH McGregor RI MacArthur T Carter (1986) ArticleTitleAvitene granulomas of colonic serosa Ann Clin Lab Sci 16 296–302
AF Chung J Menon TF Dillon (1978) ArticleTitleAcute postoperative retroperitoneal fibrosis and ureteral obstruction secondary to the use of Avitene Am J Obstet Gynecol 132 908–909
BL Erstad (2001) ArticleTitleAntifibrinolytic agents and desmopressin as hemostatic agents in cardiac surgery Ann Pharmacother 35 1075–1084
DE Harmon (1996) ArticleTitleCost/benefit analysis of pharmacologic hemostasis Ann Thorac Surg 61 S21–S25
MC Oz DM Cosgrove SuffixIII BR Badduke JD Hill MR Flannery R Palumbo N Topic (2000) ArticleTitleThe Fusion Matrix Study Group. Controlled clinical trial of a novel hemostatic agent in cardiac surgery Ann Thorac Surg 69 1376–1382
RJ Fischel RJ McKenna SuffixJr (1998) ArticleTitleBovine pericardium versus bovine collagen to buttress staples for lung reduction operations Ann Thorac Surg 65 217–219
M Sirlak S Eryilmaz L Yazicioglu U Kiziltepe Z Eyileten MS Durdu R Tasoz NT Eren A Aral B Kaya H Akalin (2003) ArticleTitleComparative study of microfibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgery J Thorac Cardiovasc Surg 126 666–670
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tomizawa, Y. Clinical benefits and risk analysis of topical hemostats: a review. J Artif Organs 8, 137–142 (2005). https://doi.org/10.1007/s10047-005-0296-x
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10047-005-0296-x